Rigel Pharmaceuticals Inc (RIGL) stock
RIGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
$42.92−0.81 (-1.85%)
Close on Nov 17, 2026Market cap $801.74MP/E 2.7Yield –
Rigel Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Rigel Pharmaceuticals's price to book ratio was 2.1× on Nov 11, 2026, against 7.9× a year earlier. Over the last 5 years it ranged from 1.3× to 124.2×, with a median of 6.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.1× | −4.6 |
| 2025 | Dec 31, 2025 | 6.7× | −22.4 |
| 2022 | Jul 29, 2022 | 29.1× | +20.0 |
| 2021 | Dec 31, 2021 | 9.2× | −2.4 |
| 2020 | Dec 31, 2020 | 11.6× | +6.4 |
| 2019 | Dec 31, 2019 | 5.2× | +2.4 |
| 2018 | Dec 31, 2018 | 2.8× | −3.7 |
| 2017 | Dec 29, 2017 | 6.5× | +3.3 |
| 2016 | Dec 30, 2016 | 3.2× | +0.4 |
| 2015 | Dec 31, 2015 | 2.8× | +1.4 |
| 2014 | Dec 31, 2014 | 1.3× | +0.4 |
| 2013 | Dec 31, 2013 | 1.0× | −1.7 |
| 2012 | Dec 31, 2012 | 2.7× | +0.5 |
| 2011 | Dec 30, 2011 | 2.2× | −0.6 |
| 2010 | Dec 31, 2010 | 2.8× | – |
See a number that looks wrong?